## Abstract Derivation of insulin producing cells (IPCs) from embryonic stem (ES) cells provides a potentially innovative form of treatment for type 1 diabetes. Here, we discuss the current state of the art, unique challenges, and future directions on generating IPCs. J. Cell. Physiol. 218: 256β263
Glucose-responsive insulin-producing cells from stem cells
β Scribed by David J. Kaczorowski; Ethan S. Patterson; William E. Jastromb; Michael J. Shamblott
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 138 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1520-7552
- DOI
- 10.1002/dmrr.330
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Islet cell replacement is considered as the optimal treatment for type I diabetes. However, the availability of human pancreatic islets for transplantation is limited. Here, we show that human bone marrowβderived mesenchymal stem cells (hMSCs) could be induced to differentiate into func
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
## Abstract In the present study, we compare the capacity of two different embryonic stem (ES) cell lines to secrete neurotrophins in response to cerebral tissue extract derived from healthy or injured rat brains. The intrinsic capacity of the embryonic cell lines BAC7 (feeder cellβdependent cultiv
## Abstract Recent experimental evidence indicates that many solid cancers have a hierarchical organization structure with a subpopulation of cancer stem cells (CSCs). The ability to identify CSCs prospectively now allows for testing the responses of CSCs to treatment modalities like radiation ther